ClinicalTrials.Veeva

Menu

Early Goal-Directed Therapy Utilizing Transpulmonary Thermodilution and Severe Burn Injury

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Completed

Conditions

Burns

Treatments

Other: Study group: TPTD device was implemented for monitoring.
Other: Control group: Patients being admitted when The advancement of transpulmonary thermodilution(TPTD) device was unavailable.

Study type

Observational

Funder types

Other

Identifiers

NCT05420610
202101364B0

Details and patient eligibility

About

This study aimed to optimize fluid resuscitation with transpulmonary thermodilution (TPTD)-guided protocol and to lower the mortality rate of the severely burned.

Enrollment

66 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (age > 18 years).
  • Major burn (as total burned surface area (TBSA) > 20% with at least second degree burn depth).
  • Admitted to the intensive care unit (ICU) of the Burn Center.

Exclusion criteria

  • Patients younger than 18 years old.
  • Patients with severe cardiopulmonary diseases, or associated with other major trauma.
  • Patient with incomplete data.

Trial design

66 participants in 1 patient group

Patients with major burn.
Description:
Adult patients (age \> 18 years) suffered from major burn which defined as total burned surface area (TBSA) \> 20% with at least second degree burn depth were admitted to the intensive care unit (ICU) of the Burn Center at a tertiary medical center were retrospectively reviewed.
Treatment:
Other: Study group: TPTD device was implemented for monitoring.
Other: Control group: Patients being admitted when The advancement of transpulmonary thermodilution(TPTD) device was unavailable.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems